Financial Freedom LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76
Closed -$545 431
2025
Q4
$545 Sell
76
-66
-46% -$521 ﹤0.01% 332
2025
Q3
$1.51K Hold
142
﹤0.01% 340
2025
Q2
$1.37K Sell
142
-60
-30% -$619 ﹤0.01% 334
2025
Q1
$3.02K Buy
202
+1
+0.5% +$15 ﹤0.01% 331
2024
Q4
$3K Buy
201
+1
+0.5% +$16 ﹤0.01% 329
2024
Q3
$3.83K Buy
200
+1
+0.5% +$21 ﹤0.01% 318
2024
Q2
$4.13K Hold
199
﹤0.01% 324
2024
Q1
$3.74K Buy
199
+1
+0.5% +$17 ﹤0.01% 316
2023
Q4
$2.85K Sell
198
-70
-26% -$952 ﹤0.01% 323
2023
Q3
$4.65K Buy
268
+2
+0.8% +$42 ﹤0.01% 316
2023
Q2
$5.54K Buy
266
+2
+0.8% +$43 ﹤0.01% 317
2023
Q1
$6.22K Buy
264
+1
+0.4% +$27 ﹤0.01% 306
2022
Q4
$7.34K Buy
+263
New +$6.72K ﹤0.01% 290

Other funds holding OGN

Financial Freedom LLC's OGN Position: Q1 2026 in Review

Financial Freedom LLC sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 76 shares — an estimated $545 sold.

Financial Freedom LLC first reported a position in OGN in Q4 2022 and held it in 13 quarters. The position peaked at $7.34K in Q4 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Financial Freedom LLC reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 76 Organon & Co shares in Q1 2026, an estimated $545.
  • Financial Freedom LLC first reported a position in Organon & Co in Q4 2022 and held it in 13 quarters.
  • Financial Freedom LLC's Organon & Co position peaked at $7.34K in Q4 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.